Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32 results about "Edta treatment" patented technology

EDTA chelation, or chelation therapy, is primarily known as a treatment for heavy metal poisoning. The letters "EDTA" stand for the chemical solution ethylenediamine tetraacetic acid.

Escherichia coli expression vector capable of controlling self-cracking of host bacterium

The invention discloses an Escherichia coli expression vector capable of controlling the self-cracking of a host bacterium, which belongs to the technical field of microbes and gene engineering. In the invention, the composition of the codon of a lysozyme gene in a T4 phage and a restriction endonuclease identification site are optimized, and the optimized T4 lysozyme gene mutation lyMu and a modified Escherichia coli expression vector are recombined to form a recombinant expression vector pEly. The expression vector pEly can be used for inducing expression of an exogenous gene, and when the exogenous gene is induced to express, T4 lysozyme is expressed. The cell undergoing induction expression is treated by ethylene diamine tetraacetic acid (EDTA) solution and then self-cracks, so that the product of expression in the cell is released. The expression vector obtained by implementing the invention can realize the express of various exogenous proteins in Escherichia coli hosts, the host bacteria release the products of expression after undergoing EDTA treatment, and thus, the recovery of the products of the expression can be promoted. The expression vector has an application prospect in fields of enzymic preparation production, polypeptide medicine production and the like.
Owner:JIANGNAN UNIV

Method for refining and purifying disodium clodronate

The invention relates to a method for refining and purifying disodium clodronate. The method comprises the following steps: S1, treatment of activated carbon by EDTA: adding the activated carbon in an EDTA solution, stirring and enabling EDTA to be in full contact with the activated carbon, and then washing the activated carbon until chloride cannot be detected; S2, activation of the activated carbon: drying the activated carbon in S1 and activating the activated carbon; S3, impurity removal of the activated carbon: treating a coarse product solution of the disodium clodronate by using the activated carbon in S2, filtering, washing and controlling pH of filtrate not to exceed 3.65; and S4, crystallization and drying: adding ethanol in the filtrate of S3 while stirring, and after white crystals are separated out, standing, carrying out suction filtration and drying to obtain refined disodium clodronate. In the step S1, the mass ratio of EDTA to the activated carbon is 1:800-1,200; and in the step S4, the volume ratio of the ethanol to the filtrate is 1.08:1-2.13:1. The contents of related substances in the product refined and purified by the method provided by the invention are remarkably reduced on the premise of guaranteeing high yield, and the product has high purity and solution clarity and good stability.
Owner:GUANGZHOU BAIYUNSHAN MINGXING PHARM CO LTD

A method for refining and purifying disodium clodronate

The invention relates to a method for refining and purifying disodium clodronate. The method comprises the following steps: S1, treatment of activated carbon by EDTA: adding the activated carbon in an EDTA solution, stirring and enabling EDTA to be in full contact with the activated carbon, and then washing the activated carbon until chloride cannot be detected; S2, activation of the activated carbon: drying the activated carbon in S1 and activating the activated carbon; S3, impurity removal of the activated carbon: treating a coarse product solution of the disodium clodronate by using the activated carbon in S2, filtering, washing and controlling pH of filtrate not to exceed 3.65; and S4, crystallization and drying: adding ethanol in the filtrate of S3 while stirring, and after white crystals are separated out, standing, carrying out suction filtration and drying to obtain refined disodium clodronate. In the step S1, the mass ratio of EDTA to the activated carbon is 1:800-1,200; and in the step S4, the volume ratio of the ethanol to the filtrate is 1.08:1-2.13:1. The contents of related substances in the product refined and purified by the method provided by the invention are remarkably reduced on the premise of guaranteeing high yield, and the product has high purity and solution clarity and good stability.
Owner:GUANGZHOU BAIYUNSHAN MINGXING PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products